Regis Healthcare Limited
ASX:REG.AX
6.51 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,014.051 | 771.482 | 717.895 | 685.867 | 666.152 | 646.855 | 594.397 | 565.483 | 480.745 | 437.508 | 409.543 | 353.603 |
Cost of Revenue
| 838.803 | 775.264 | 712.719 | 618.327 | 585.267 | 485.749 | 432.336 | 398.261 | 340.55 | 304.755 | 238.131 | 211.698 |
Gross Profit
| 175.248 | -3.782 | 5.176 | 67.54 | 80.885 | 161.106 | 162.061 | 167.222 | 140.195 | 132.753 | 171.412 | 141.905 |
Gross Profit Ratio
| 0.173 | -0.005 | 0.007 | 0.098 | 0.121 | 0.249 | 0.273 | 0.296 | 0.292 | 0.303 | 0.419 | 0.401 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 37.561 | 58.643 | 42.618 | 39.551 | 38.275 | 32.808 | 27.636 | 26.057 | 21.433 | 23.45 | 9.34 | 7.677 |
Selling & Marketing Expenses
| 42.912 | 13.942 | -1.34 | 11.577 | 16.947 | 20.759 | 18.01 | 16.586 | 12.844 | 1.425 | 1.177 | 1.555 |
SG&A
| 80.473 | 72.585 | 41.278 | 51.128 | 55.222 | 53.567 | 45.646 | 42.643 | 34.277 | 35.203 | 53.674 | 47.06 |
Other Expenses
| 0 | 665.914 | 589.47 | 582.887 | 533.277 | 461.53 | 422.345 | 406.493 | 335.061 | 334.592 | 0 | 0 |
Operating Expenses
| 80.473 | 72.585 | 41.278 | 51.128 | 55.222 | 79.762 | 77.086 | 73.601 | 69.16 | 46.63 | 125.236 | 101.2 |
Operating Income
| 94.775 | -76.367 | -36.102 | 16.412 | 25.663 | 73.607 | 88.833 | 95.074 | 84.064 | 78.636 | 45.411 | 42.735 |
Operating Income Ratio
| 0.093 | -0.099 | -0.05 | 0.024 | 0.039 | 0.114 | 0.149 | 0.168 | 0.175 | 0.18 | 0.111 | 0.121 |
Total Other Income Expenses Net
| -122.879 | 35.987 | -19.083 | 12.738 | -19.945 | -3.98 | -12.061 | -7.356 | -13.983 | -0.55 | -19.783 | -18.49 |
Income Before Tax
| -28.104 | -40.38 | -55.185 | 29.15 | 5.718 | 69.627 | 76.772 | 87.718 | 70.081 | 78.086 | 25.628 | 24.245 |
Income Before Tax Ratio
| -0.028 | -0.052 | -0.077 | 0.043 | 0.009 | 0.108 | 0.129 | 0.155 | 0.146 | 0.178 | 0.063 | 0.069 |
Income Tax Expense
| 6.689 | -11.929 | -16.386 | 9.201 | 6.434 | 18.73 | 22.903 | 26.617 | 23.546 | 20.572 | 24.58 | 7.155 |
Net Income
| -21.415 | -28.451 | -38.799 | 19.949 | -0.716 | 50.897 | 53.869 | 61.101 | 46.067 | 57.514 | 1.048 | 17.09 |
Net Income Ratio
| -0.021 | -0.037 | -0.054 | 0.029 | -0.001 | 0.079 | 0.091 | 0.108 | 0.096 | 0.131 | 0.003 | 0.048 |
EPS
| -0.071 | -0.095 | -0.13 | 0.066 | -0.002 | 0.17 | 0.18 | 0.2 | 0.15 | 0.21 | 0.004 | 0.049 |
EPS Diluted
| -0.071 | -0.095 | -0.13 | 0.066 | -0.002 | 0.17 | 0.18 | 0.2 | 0.15 | 0.21 | 0.004 | 0.049 |
EBITDA
| 93.808 | 50.097 | 67.005 | 60.305 | 69.729 | 107.539 | 116.415 | 124.579 | 105.918 | 97.55 | 62.753 | 63.989 |
EBITDA Ratio
| 0.093 | 0.065 | 0.093 | 0.088 | 0.105 | 0.166 | 0.196 | 0.22 | 0.22 | 0.223 | 0.153 | 0.181 |